Quantitative Polymerase Chain Reaction (PCR) Assay for the Wilms' Tumor (WT) Gene - Vietnam Registration 2402221ĐKLH/BYT-HTTB
Access comprehensive regulatory information for Quantitative Polymerase Chain Reaction (PCR) Assay for the Wilms' Tumor (WT) Gene in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402221ĐKLH/BYT-HTTB and manufactured by Veracyte SAS. The authorized representative in Vietnam is CÔNG TY TNHH THIẾT BỊ Y TẾ PHƯƠNG ĐÔNG.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
2402221ĐKLH/BYT-HTTB
000.00.04.G18-200419-0003
ipsogen® WT1 ProfileQuant® Kit
676923
Technical Details
The Ipsogen WT1 ProfileQuant Kit is used to quantify the mRNA of the Wilms' tumor (WT) gene from the total RNA isolated from patients with acute myeloid leukemia (AML). The results are used to support early treatment response monitoring and minimal residual disease (MRD) monitoring
Dates and Status
Aug 27, 2024